JP2024051082A5 - - Google Patents

Download PDF

Info

Publication number
JP2024051082A5
JP2024051082A5 JP2024027527A JP2024027527A JP2024051082A5 JP 2024051082 A5 JP2024051082 A5 JP 2024051082A5 JP 2024027527 A JP2024027527 A JP 2024027527A JP 2024027527 A JP2024027527 A JP 2024027527A JP 2024051082 A5 JP2024051082 A5 JP 2024051082A5
Authority
JP
Japan
Prior art keywords
seq
amino acids
region
capsid polypeptide
aav2 capsid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2024027527A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024051082A (ja
JP7741575B2 (ja
Filing date
Publication date
Priority claimed from PCT/US2019/031307 external-priority patent/WO2019221992A1/en
Application filed filed Critical
Publication of JP2024051082A publication Critical patent/JP2024051082A/ja
Publication of JP2024051082A5 publication Critical patent/JP2024051082A5/ja
Application granted granted Critical
Publication of JP7741575B2 publication Critical patent/JP7741575B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2024027527A 2018-05-15 2024-02-27 改善された遺伝子送達特性を示すウイルスベクター Active JP7741575B2 (ja)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201862671949P 2018-05-15 2018-05-15
US62/671,949 2018-05-15
PCT/US2019/031307 WO2019221992A1 (en) 2018-05-15 2019-05-08 Viral vectors exhibiting improved gene delivery properties
JP2020564154A JP2021522840A (ja) 2018-05-15 2019-05-08 改善された遺伝子送達特性を示すウイルスベクター

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2020564154A Division JP2021522840A (ja) 2018-05-15 2019-05-08 改善された遺伝子送達特性を示すウイルスベクター

Publications (3)

Publication Number Publication Date
JP2024051082A JP2024051082A (ja) 2024-04-10
JP2024051082A5 true JP2024051082A5 (https=) 2024-04-19
JP7741575B2 JP7741575B2 (ja) 2025-09-18

Family

ID=68540740

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2020564154A Withdrawn JP2021522840A (ja) 2018-05-15 2019-05-08 改善された遺伝子送達特性を示すウイルスベクター
JP2024027527A Active JP7741575B2 (ja) 2018-05-15 2024-02-27 改善された遺伝子送達特性を示すウイルスベクター

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2020564154A Withdrawn JP2021522840A (ja) 2018-05-15 2019-05-08 改善された遺伝子送達特性を示すウイルスベクター

Country Status (6)

Country Link
US (1) US12338267B2 (https=)
EP (1) EP3813845A4 (https=)
JP (2) JP2021522840A (https=)
AU (1) AU2019270900B2 (https=)
CA (1) CA3100066A1 (https=)
WO (1) WO2019221992A1 (https=)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3461836A1 (en) 2017-09-28 2019-04-03 Universität zu Köln Mutated adeno-associated viral capsid proteins for chemical coupling of ligands, nanoparticles or drugs via thioether binding and production method thereof
EP4069856A1 (en) * 2019-12-04 2022-10-12 Sangamo Therapeutics, Inc. Novel compositions and methods for producing recombinant aav
EP4097121A1 (en) * 2020-01-29 2022-12-07 Genzyme Corporation Modified adeno-associated viral capsid proteins for ocular gene therapy and methods of use thereof
CN111349148A (zh) * 2020-03-13 2020-06-30 辉大(上海)生物科技有限公司 一种腺相关病毒载体及其用途
KR20230005941A (ko) * 2020-05-01 2023-01-10 트러스티스 오브 보스톤 칼리지 향상된 유전자 요법을 위한 아데노-관련 바이러스(aav)의 제어된 변형
CA3222914A1 (en) * 2021-06-23 2022-12-29 Dyno Therapeutics, Inc. Capsid variants and methods of using the same
WO2023283962A1 (en) * 2021-07-16 2023-01-19 Huigene Therapeutics Co., Ltd. Modified aav capsid for gene therapy and methods thereof
KR20240095539A (ko) 2021-10-08 2024-06-25 디노 테라퓨틱스, 인코포레이티드 캡시드 변이체 및 이의 사용 방법
EP4508065A2 (en) * 2022-04-15 2025-02-19 Dyno Therapeutics, Inc. Capsid variants and methods of using the same
EP4508228A2 (en) * 2022-04-15 2025-02-19 Dyno Therapeutics, Inc. Capsid variants and methods of using the same
WO2026084101A1 (ko) * 2024-10-18 2026-04-23 주식회사 아바타테라퓨틱스 아데노연관바이러스 변이체

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6156303A (en) 1997-06-11 2000-12-05 University Of Washington Adeno-associated virus (AAV) isolates and AAV vectors derived therefrom
CA2373110A1 (en) 2000-03-14 2001-09-20 Neurologix, Inc. Production of chimeric capsid vectors
WO2002053703A2 (en) 2001-01-05 2002-07-11 Children's Hospital, Inc. Aav2 vectors and methods
PT1453547T (pt) 2001-12-17 2016-12-28 Univ Pennsylvania Sequências do vírus adeno-associado (aav) do serotipo 8, vetores contendo as mesmas, e utilizações destas
EP1486567A1 (en) 2003-06-11 2004-12-15 Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts Improved adeno-associated virus (AAV) vector for gene therapy
US9441244B2 (en) 2003-06-30 2016-09-13 The Regents Of The University Of California Mutant adeno-associated virus virions and methods of use thereof
EP2345731B1 (en) 2003-09-30 2015-10-21 The Trustees of the University of Pennsylvania Adeno-associated virus (AAV) clades, sequences, vectors containing same, and uses thereof
US9725485B2 (en) * 2012-05-15 2017-08-08 University Of Florida Research Foundation, Inc. AAV vectors with high transduction efficiency and uses thereof for gene therapy
ES2714007T3 (es) 2007-04-09 2019-05-24 Univ Florida Composiciones de vectores rAAV que tienen proteínas de la cápside modificadas en tirosina y métodos para su uso
WO2009108274A2 (en) * 2008-02-26 2009-09-03 The University Of North Carolina At Chapel Hill Methods and compositions for adeno-associated virus (aav) with hi loop mutations
WO2013170078A1 (en) 2012-05-09 2013-11-14 Oregon Health & Science University Adeno associated virus plasmids and vectors
GB201403684D0 (en) 2014-03-03 2014-04-16 King S College London Vector
LT3137497T (lt) 2014-05-02 2021-07-26 Genzyme Corporation Aav vektoriai, skirti tinklainės ir cns genų terapijai
JP7406783B2 (ja) * 2015-12-14 2023-12-28 ザ ユニバーシティ オブ ノース カロライナ アット チャペル ヒル パルボウイルスベクターの高められた送達のための改変キャプシドタンパク質
WO2017147477A1 (en) * 2016-02-26 2017-08-31 University Of Florida Research Foundation, Inc. Aav heparin mutants that display significantly improved eye and brain transduction

Similar Documents

Publication Publication Date Title
JP2024051082A5 (https=)
KR100379569B1 (ko) 개기원의아데노바이러스벡터및유전자치료에서이의사용방법
JP5097714B2 (ja) E1領域内の発現カセットと不活性化されたe2bポリメラーゼを有するアデノウイルス発現ベクター
JP2023134488A5 (https=)
WO2005121343A1 (en) Construction of oncolytic adenovirus recombinant specifically expressing immune modulatory factor gm-csf in tumor cells and uses thereof
CA2343653A1 (en) Recombinant newcastle disease virus rna expression systems and vaccines
CN111218477B (zh) 靶向感染哺乳动物细胞的禽4型腺病毒载体及其应用
US10851359B2 (en) Anti-tumor medicament based on adenovirus
CN101517079A (zh) 非复制型副粘病毒科病毒载体
JPWO2020218419A5 (https=)
JP2007530004A (ja) 疾患を処置するためのサブグループbアデノウイルスベクター
WO2019091457A1 (zh) 肝脏特异性转录调控序列及其应用
JP2023538112A5 (https=)
CN117448284B (zh) 一种稳定传代的表达egfp的重组坦布苏病毒及构建方法
WO2001092299A9 (en) Adenovirus particles with mutagenized fiber proteins
CN117646032B (zh) Bhv-1的反向遗传操作系统及其在病毒拯救中的应用
CN120843601B (zh) pIX区域携带抗原的衣壳武装化腺病毒、构建方法及应用
CN118547012B (zh) 一种SARS-CoV-2 S病毒样颗粒递送系统及其应用
WO2025065890A1 (zh) 一种重组腺相关病毒颗粒、重组腺相关病毒载体系统及其应用
US7264818B2 (en) BAV packaging regions and E1 transcriptional control regions
US20020137213A1 (en) Adenovirus particles with mutagenized fiber proteins
WO2023210616A1 (ja) Rnaウイルス由来のキメラエンベロープタンパク質及び該タンパク質を持つrnaウイルスベクター
Brown Reovirus M1 gene expression
CN121426972A (zh) 基于λN的基因编辑
JP2004290018A (ja) 変異型アデノウイルスベクター